Predictors of red cell alloimmunization in multitransfused egyptian patients with β-thalassemia

Archives of Pathology and Laboratory Medicine

Volumn 138, Issue 5, 2014, Pages 684-688

  Hussein, Eiman ^a   Desooky, Nermeen ^a   Rihan, Abeer ^a   Kamal, Abeer ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; RHO(D) ANTIGEN;

ADOLESCENT; ARTICLE; BETA THALASSEMIA; BLOOD; BLOOD GROUP ABO SYSTEM; BLOOD GROUP RHESUS SYSTEM; BLOOD TRANSFUSION; CHILD; EGYPT; ERYTHROCYTE; FEMALE; HUMAN; IMMUNOLOGY; MALE; PREVALENCE; RHESUS ISOIMMUNIZATION; RISK FACTOR;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; EGYPT; ERYTHROCYTES; FEMALE; HUMANS; ISOANTIBODIES; MALE; PREVALENCE; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM; RISK FACTORS;

EID: 84900499681     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2013-0016-OA     Document Type: Article

References (27)

1. Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusion dependent thalassemia patients of predominantly Asian descent. Blood. 2000;96(10):3369- 3373
2. Cianciulli P, Sorrentino F, Morino L, et al. Radiotherapy combined with erythropoietin for the treatment of extramedullary hematopoiesis in an alloimmunized patient with thalassemia intermedia. Ann Hematol. 1996;72(6): 379-381 (Pubitemid 26229980)
3. Barrai L, Rosito A, Cappellozza G, et al. b-Thalassemia in the Po Delta: selection, geography, and population structure. Am J Hum Genet. 1984;36(5): 1121-1134 (Pubitemid 15205742)
4. Blumberg N, Ross K, Avila E, Peck K. Should chronic transfusions be matched for antigens other than ABO and Rh (D). Vox Sang. 1984;47(3):205-208
5. Walker RH, Lin DT, Hartrick MB. Alloimmunization following blood transfusion. Arch Pathol Lab Med. 1989;113(3):254-261 (Pubitemid 19084336)
6. Karimi M, Nikrooz P, Kashef S, Jamalian N, Davatolhagh Z. RBC alloimmunization in blood transfusion dependent B thalassemia patients in southern Iran. Int J Lab Hematol. 2007;29(5):321-626
7. Bhatti FA, Salamat N, Madeem A, Shabbir N. Red cell immunization in bthalassemia major. J Coll Physicians Surg Pak. 2004;14(11):657-560
8. Bilwani F, Kakepoto GN, Adil SN, Usman M, Hassan F, Khurshid M. Frequency of irregular red cell alloantibodies in patients with thalassemia major: a bicenter study. J Pak Med Assoc. 2005;55(12):563-565
9. Azarkeivan A, Ansari S, Ahmadi MH, et al. Blood transfusion and alloimmunization in patients with thalassemia: multicenter study. Pediatr Hematol Oncol. 201128(6):479-485
10. Gupta R, Singh DK, Singh B, Rusia U. Alloimmunization to red cells in thalassemics: emerging problem and future strategies. Transfus Apher Sci. 2011; 45(2):167-170
11. Lannan KL, Sahler J, Spinelli SL, Phipps RP, Blumberg N. Transfusion immunomodulation - the case for leukoreduced and (perhaps) washed transfusions. Blood Cells Mol Dis. 2013;50(1):61-68
12. Wang LY, Liang DC, Liu HC, et al. Alloimmunization among patients with transfusion- dependent thalassemia in Taiwan. Transfus Med. 2006;16(3):200- 203
13. Grady RW, Akbar AN, Giardina PJ, Hilgartner MW, de Sousa M. Disproportionate lymphoid cell subsets in thalassemia major: the relative contributions of transfusion and splenectomy. Br J Haematol. 1985;59(4):713- 724 (Pubitemid 15133664)
14. Hodge G, Lloyd JV, Hodge S, Story C, Han P. Functional lymphocyte immunophenotypes observed in thalassaemia and haemophilia patients receiving current blood product preparations. Br J Haematol. 1999;10(3):817-825 (Pubitemid 29277047)
15. Smit Sibinga CT . Immune effects of blood transfusion. Curr Opin Hematol. 1999;6(6):442-445 (Pubitemid 29503156)
16. Chou ST, Liem RI, Thompson AA. Challenges of alloimmunization in patients with haemoglobinopathies. Br J Haematol. 2012;159(4):394-404
17. Bauer MP, Wiersum-Osselton J, Schipperus M, Vandenbroucke JP, Bri ? et, E. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion. 2007;47(11):2066-2071 (Pubitemid 47623978)
18. Ameen R, Al-Shemmari S, Al-Humood S, Chowdhury RI, Al-Eyaadi O, Al- Bashir A. RBC alloimmunization and autoimmunization among transfusion dependent Arab thalassemia patients. Transfusion. 2003;43(11):1604-1610 (Pubitemid 37371832)
19. el-Danasoury AS, Eissa DG, Abdo RM, Elalfy MS. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program. Transfusion. 2012;52(1):43-47
20. Thompson AA, Cunningham MJ, Singer ST, et al Thalassemia Clinical Research Network Investigators. Red cell alloimmunization in a diverse population of transfused patients with thalassaemia. Br J Haematol. 2011; 153(1):121-128
21. Fluit CR, Kunst VA, Drenthe-Schonk AM. Incidence of red cell antibodies after multiple blood transfusion. Transfusion. 1990;30(6):532-535 (Pubitemid 20244191)
22. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease: the cooperative study of sickle cell disease. Blood. 1990;76(7):1431-1437 (Pubitemid 20342762)
23. Carson TH, ed. Standards for Blood Banks and Transfusion Services. 28th ed. Bethesda, MD: AABB; 2012
24. Hussein E, Teruya J. Weak D types in the Egyptian population. Am J Clin Pathol. 2013;139(6):806-811
25. Cruz BR, Chiba AK, Moritz E, Bordin JO. RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes. Transfus Med. 2012;22(2):84-89
26. Felgel WA. http://www.ncbi.nlm.nih.gov/pubmed/17053462 How I manage donors and patients with a weak D phenotype. Curr Opin Hematol. 2006; 13(6):476-483
27. Hmida S, Mojaat N, Maamar M, Bejaoui M, Mediouni M, Boukef K. Red cell alloantibodies in patients with haemoglobinopathies. Nouv Rev Fr Hematol. 1994;36(5):363-366 (Pubitemid 24352497)